- Home
- XXII vs PLRZ Comparison
XXII vs PLRZ Comparison
Compare XXII & PLRZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XXII
- PLRZ
- Stock Information
- Founded
- XXII 1998
- PLRZ 2005
- Country
- XXII United States
- PLRZ Israel
- Employees
- XXII N/A
- PLRZ N/A
- Industry
- XXII Medicinal Chemicals and Botanical Products
- PLRZ
- Sector
- XXII Health Care
- PLRZ
- Exchange
- XXII Nasdaq
- PLRZ NYSE
- Market Cap
- XXII 4.0M
- PLRZ 3.4M
- IPO Year
- XXII N/A
- PLRZ 2024
- Fundamental
- Price
- XXII $0.09
- PLRZ $0.81
- Analyst Decision
- XXII
- PLRZ
- Analyst Count
- XXII 0
- PLRZ 0
- Target Price
- XXII N/A
- PLRZ N/A
- AVG Volume (30 Days)
- XXII 9.6M
- PLRZ 639.1K
- Earning Date
- XXII 11-12-2024
- PLRZ 11-25-2024
- Dividend Yield
- XXII N/A
- PLRZ N/A
- EPS Growth
- XXII N/A
- PLRZ N/A
- EPS
- XXII N/A
- PLRZ N/A
- Revenue
- XXII $9,918,000.00
- PLRZ N/A
- Revenue This Year
- XXII $56.94
- PLRZ N/A
- Revenue Next Year
- XXII $2.98
- PLRZ N/A
- P/E Ratio
- XXII $0.03
- PLRZ N/A
- Revenue Growth
- XXII N/A
- PLRZ N/A
- 52 Week Low
- XXII $0.09
- PLRZ $0.77
- 52 Week High
- XXII $5.28
- PLRZ $1.97
- Technical
- Relative Strength Index (RSI)
- XXII 31.38
- PLRZ N/A
- Support Level
- XXII $0.09
- PLRZ N/A
- Resistance Level
- XXII $0.13
- PLRZ N/A
- Average True Range (ATR)
- XXII 0.01
- PLRZ 0.00
- MACD
- XXII 0.01
- PLRZ 0.00
- Stochastic Oscillator
- XXII 10.51
- PLRZ 0.00
About XXII 22nd Century Group Inc.
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.
About PLRZ POLYRIZON LTD
Polyrizon Ltd is a clinical development stage biotech company specializing in the development of nasal gels to provide preventative treatment to protect against a wide cross-section of viruses, including certain variants of COVID-19 that are also considered to cause more infections and spread faster than the original strain of the virus (the CDC expects that additional variants of the virus will continue to occur), influenza, allergens, and other toxins. Its technology platforms are Capture & Contain and Trap & Target.